Home

Emcure Pharmaceuticals Ltd EPS

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

EPS

₹ 36.34

Last updated on: Jun 03, 2025

Key Highlights

  • The Earning per Share of Emcure Pharmaceuticals Ltd is ₹ 36.34 as of 03 Jun 25 .
  • The earning per share of Emcure Pharmaceuticals Ltd changed from ₹ 7.21 to ₹ 9.97 over 8 quarters. This represents a CAGR of 17.59% .

Historical Earning per Share of Emcure Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Emcure Pharmaceuticals Ltd

Market Cap

25,043 Cr

EPS

36.3

P/E Ratio (TTM)

36.4

P/B Ratio (TTM)

5.6

Day’s High

1383.6

Day’s Low

1311.05

DTE

0.2

ROE

15.3

52 Week High

1577.5

52 Week Low

890.0

ROCE

19.9

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Jun 20251321.65
02 Jun 20251349.65
30 May 20251330.1
29 May 20251351.1
28 May 20251346.2
27 May 20251358.85
26 May 20251411.95
23 May 20251288.65
22 May 20251171.5
21 May 20251073.55

BlinkX Score for Emcure Pharmaceuticals Ltd

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

25,043

Asset Value

Value addition

5.0 X

4,171

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Emcure Pharmaceuticals Ltd25043
Sun Pharmaceutical Industries Ltd400125
Divis Laboratories Ltd173358
Cipla Ltd118949
Torrent Pharmaceuticals Ltd106083
Dr Reddys Laboratories Ltd104190

Historical Market Cap of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Emcure Pharmaceuticals Ltd News Hub

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs

Read more

13 Aug 24

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank

Read more

13 Aug 24

Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Emcure Pharmaceuticals to declare Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202

Read more

10 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Emcure Pharmaceuticals Ltd

What is the EPS of Emcure Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Emcure Pharmaceuticals Ltd is 36.34. An EPS is the amount of net income attributed to each share of a common stock.

How is Emcure Pharmaceuticals Ltd EPS calculated?

The EPS of Emcure Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Emcure Pharmaceuticals Ltd report its EPS?

Emcure Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Emcure Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Emcure Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Emcure Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Emcure Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions